vs

Side-by-side financial comparison of OneSpan Inc. (OSPN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $65.9M, roughly 1.3× OneSpan Inc.). OneSpan Inc. runs the higher net margin — 17.5% vs -38.1%, a 55.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 4.1%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 4.0%).

OneSpan Inc. is an information security company based in Boston, Massachusetts. Services include an internet fraud prevention platform, multi-factor authentication tools and electronic signature software.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

OSPN vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.3× larger
PRCT
$83.1M
$65.9M
OSPN
Growing faster (revenue YoY)
PRCT
PRCT
+16.1% gap
PRCT
20.2%
4.1%
OSPN
Higher net margin
OSPN
OSPN
55.6% more per $
OSPN
17.5%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
4.0%
OSPN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
OSPN
OSPN
PRCT
PRCT
Revenue
$65.9M
$83.1M
Net Profit
$11.6M
$-31.6M
Gross Margin
73.6%
64.9%
Operating Margin
22.5%
-4.1%
Net Margin
17.5%
-38.1%
Revenue YoY
4.1%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.39
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OSPN
OSPN
PRCT
PRCT
Q1 26
$65.9M
$83.1M
Q4 25
$62.9M
$76.4M
Q3 25
$57.1M
$83.3M
Q2 25
$59.8M
$79.2M
Q1 25
$63.4M
$69.2M
Q4 24
$61.2M
$68.2M
Q3 24
$56.2M
$58.4M
Q2 24
$60.9M
$53.4M
Net Profit
OSPN
OSPN
PRCT
PRCT
Q1 26
$11.6M
$-31.6M
Q4 25
$43.5M
$-29.8M
Q3 25
$6.5M
$-21.4M
Q2 25
$8.3M
$-19.6M
Q1 25
$14.5M
$-24.7M
Q4 24
$28.8M
$-18.9M
Q3 24
$8.3M
$-21.0M
Q2 24
$6.6M
$-25.6M
Gross Margin
OSPN
OSPN
PRCT
PRCT
Q1 26
73.6%
64.9%
Q4 25
73.6%
60.6%
Q3 25
73.6%
64.8%
Q2 25
73.5%
65.4%
Q1 25
74.3%
63.9%
Q4 24
74.0%
64.0%
Q3 24
73.9%
63.2%
Q2 24
66.2%
59.0%
Operating Margin
OSPN
OSPN
PRCT
PRCT
Q1 26
22.5%
-4.1%
Q4 25
19.9%
-40.6%
Q3 25
14.4%
-27.8%
Q2 25
17.6%
-28.0%
Q1 25
27.1%
-39.7%
Q4 24
19.3%
-28.9%
Q3 24
20.0%
-38.4%
Q2 24
12.5%
-50.3%
Net Margin
OSPN
OSPN
PRCT
PRCT
Q1 26
17.5%
-38.1%
Q4 25
69.2%
-39.1%
Q3 25
11.4%
-25.7%
Q2 25
13.9%
-24.7%
Q1 25
22.9%
-35.8%
Q4 24
47.1%
-27.6%
Q3 24
14.7%
-35.9%
Q2 24
10.8%
-48.0%
EPS (diluted)
OSPN
OSPN
PRCT
PRCT
Q1 26
$0.39
$-0.56
Q4 25
$1.13
$-0.54
Q3 25
$0.17
$-0.38
Q2 25
$0.21
$-0.35
Q1 25
$0.37
$-0.45
Q4 24
$0.73
$-0.34
Q3 24
$0.21
$-0.40
Q2 24
$0.17
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OSPN
OSPN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$49.8M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$272.0M
$347.7M
Total Assets
$383.1M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OSPN
OSPN
PRCT
PRCT
Q1 26
$49.8M
$245.6M
Q4 25
$70.5M
$286.5M
Q3 25
$85.6M
$294.3M
Q2 25
$92.9M
$302.7M
Q1 25
$105.2M
$316.2M
Q4 24
$83.2M
$333.7M
Q3 24
$77.5M
$196.8M
Q2 24
$63.8M
$214.1M
Total Debt
OSPN
OSPN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
OSPN
OSPN
PRCT
PRCT
Q1 26
$272.0M
$347.7M
Q4 25
$271.8M
$365.9M
Q3 25
$238.3M
$380.3M
Q2 25
$242.5M
$385.8M
Q1 25
$231.1M
$389.2M
Q4 24
$212.5M
$402.2M
Q3 24
$194.6M
$241.2M
Q2 24
$178.6M
$251.8M
Total Assets
OSPN
OSPN
PRCT
PRCT
Q1 26
$383.1M
$487.1M
Q4 25
$397.7M
$508.1M
Q3 25
$343.5M
$511.5M
Q2 25
$357.1M
$513.1M
Q1 25
$333.8M
$519.4M
Q4 24
$338.7M
$534.0M
Q3 24
$289.3M
$374.1M
Q2 24
$286.9M
$374.4M
Debt / Equity
OSPN
OSPN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OSPN
OSPN
PRCT
PRCT
Operating Cash FlowLast quarter
$28.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OSPN
OSPN
PRCT
PRCT
Q1 26
$28.2M
Q4 25
$12.6M
$-10.3M
Q3 25
$11.3M
$-6.6M
Q2 25
$6.2M
$-15.0M
Q1 25
$29.4M
$-17.0M
Q4 24
$12.4M
$-32.4M
Q3 24
$14.0M
$-18.8M
Q2 24
$2.3M
$-15.7M
Free Cash Flow
OSPN
OSPN
PRCT
PRCT
Q1 26
Q4 25
$9.6M
$-12.2M
Q3 25
$8.8M
$-9.5M
Q2 25
$4.4M
$-17.8M
Q1 25
$27.7M
$-18.8M
Q4 24
$10.5M
$-33.6M
Q3 24
$12.0M
$-19.0M
Q2 24
$26.0K
$-16.8M
FCF Margin
OSPN
OSPN
PRCT
PRCT
Q1 26
Q4 25
15.3%
-15.9%
Q3 25
15.4%
-11.4%
Q2 25
7.3%
-22.5%
Q1 25
43.8%
-27.2%
Q4 24
17.1%
-49.2%
Q3 24
21.4%
-32.6%
Q2 24
0.0%
-31.4%
Capex Intensity
OSPN
OSPN
PRCT
PRCT
Q1 26
Q4 25
4.7%
2.4%
Q3 25
4.4%
3.4%
Q2 25
3.1%
3.5%
Q1 25
2.6%
2.7%
Q4 24
3.2%
1.7%
Q3 24
3.5%
0.4%
Q2 24
3.7%
2.0%
Cash Conversion
OSPN
OSPN
PRCT
PRCT
Q1 26
2.44×
Q4 25
0.29×
Q3 25
1.74×
Q2 25
0.75×
Q1 25
2.02×
Q4 24
0.43×
Q3 24
1.69×
Q2 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OSPN
OSPN

Product and license$35.5M54%
Services and other$30.4M46%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons